Mårten Österlund
Founder bei MEDA AB
Profil
Mårten Österlund is the founder of Affibody AB, established in 1998, and Meda AB, established in 1999, where he holds the title of Executive VP-Business Development & Legal starting in 2014.
Dr. Österlund is also the founder of Karobio AB.
Currently, Dr. Österlund holds positions as Director at Annexin Pharmaceuticals AB, Unimedic Pharma Holding AB, Pharma Way AB, and Neobiomics AB.
In the past, he served as Co-Chief Executive Officer at Madaus GmbH.
Dr. Österlund obtained a doctorate degree from the University of Uppsala.
Aktive Positionen von Mårten Österlund
| Unternehmen | Position | Beginn |
|---|---|---|
| MEDA AB | Founder | 01.01.1999 |
| ANNEXIN PHARMACEUTICALS AB | Director/Board Member | 01.01.2021 |
| Neobiomics AB | Director/Board Member | - |
| Pharma Way AB | Director/Board Member | - |
| Unimedic Pharma Holding AB | Director/Board Member | - |
Ehemalige bekannte Positionen von Mårten Österlund
| Unternehmen | Position | Ende |
|---|---|---|
| Karobio AB | Founder | - |
Affibody AB
 Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Founder | - |
Madaus GmbH
 Madaus GmbH Pharmaceuticals: MajorHealth Technology MADAUS GmbH manufactures pharmaceutical products. It provides medicines of plant origin together with products for 'Natural Prevention'. The firm offers products to treat the fundamental causes of disease, not merely the symptoms, and thereby to prevent diseases from occurring or at least from becoming chronic. The company was founded in 1919 by Gerhard Madaus, Friedemund Madaus and Hans Madaus and is headquartered in Cologne, Germany. | Chief Executive Officer | - |
Ausbildung von Mårten Österlund
| University of Uppsala | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ANNEXIN PHARMACEUTICALS AB | Health Technology |
| Private Unternehmen | 7 |
|---|---|
Affibody AB
Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Commercial Services |
Meda AB
 Meda AB Pharmaceuticals: MajorHealth Technology Meda AB engages in the research, development, manufacture, and sale of pharmaceutical and medical products. It offers respiratory, dermatology, pain and inflammation, consumer healthcare, and over-the-counter products. The company was founded by Gert Lennart Perlhagen in 1999 and is headquartered in Solna, Sweden. | Health Technology |
Madaus GmbH
Madaus GmbH Pharmaceuticals: MajorHealth Technology MADAUS GmbH manufactures pharmaceutical products. It provides medicines of plant origin together with products for 'Natural Prevention'. The firm offers products to treat the fundamental causes of disease, not merely the symptoms, and thereby to prevent diseases from occurring or at least from becoming chronic. The company was founded in 1919 by Gerhard Madaus, Friedemund Madaus and Hans Madaus and is headquartered in Cologne, Germany. | Health Technology |
| Karobio AB | |
| Unimedic Pharma Holding AB | |
| Pharma Way AB | |
| Neobiomics AB |
